• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Domain Associates

edit

Founded in 1985, Domain Associates, L.L.C. is a venture capital firm with an exclusive focus on life sciences. With $2 billion of capital under management, Domain is headquartered in Princeton, NJ with a second office in San Diego, CA.

Domain’s three major investment segments are pharmaceuticals, specialty pharmaceuticals, and medical devices, while additional areas of interest include biomaterials, bioinstrumentation, and diagnostics. The Partners of Domain have a total of close to 200 person-years of experience among them in the healthcare/venture capital industries and have been involved in the formation and growth of more than 200 life-sciences companies. The highly focused network, experience, and reputation of this team have made it one of the top private-equity groups participating in the healthcare field.

Milestones

edit

• 
  Domain Associates invested in Carticept Medical. (1/18/12)
  Posted 1/18/12 at 5:26pm via finsmes.com
• 
  Domain Associates invested in Aria Diagnostics. (1/9/12)
  Posted 1/9/12 at 8:59pm via ariadx.com
• 
  Domain Associates invested in IntegenX. (12/13/11)
  Posted 12/13/11 at 7:47pm via finsmes.com
• 
  Domain Associates invested in Sera Prognostics. (11/15/11)
  Posted 11/15/11 at 6:13pm via seraprognostics.com
• 
  Domain Associates invested in CoLucid Pharmaceuticals. (8/30/11)
  Posted 8/30/11 at 7:57pm via prnewswire.com
• 
  Domain Associates invested in Benvenue Medical. (4/18/11)
  Posted 4/18/11 at 7:35pm via bizjournals.com
• 
  Domain Associates invested in CoDa Therapeutics. (4/18/11)
  Posted 4/18/11 at 6:12pm via pehub.com
• 
  Domain Associates invested in BioNanomatrix. (3/17/11)
  Posted 3/17/11 at 6:28pm via bionanomatrix.com
• 
  Domain Associates invested in Astute Medical. (3/8/11)
  Posted 3/8/11 at 7:26pm via msn.com
• 
  Domain Associates invested in IntegenX. (2/4/11)
  Posted 2/4/11 at 6:22pm via bizjournals.com
• 
  Domain Associates invested in Nuon Therapeutics. (8/12/10)
  Posted 10/31/10 at 8:27pm via bizjournals.com
• 
  Domain Associates invested in Zogenix. (7/13/10)
  Posted 10/31/10 at 7:28pm via zogenix.com
• 
  Domain Associates invested in Achillion Pharmaceuticals. (8/18/10)
  Posted 10/31/10 at 6:24pm via achillion.com
• 
  Domain Associates invested in aTyr Pharma. (10/26/10)
  Posted 10/26/10 at 11:01pm via atyrpharma.com
• 
  Domain Associates invested in ProteinSimple. (10/14/10)
  Posted 10/22/10 at 4:00am via xconomy.com
• 
  Domain Associates invested in Tobira Therapeutics. (9/29/10)
  Posted 9/30/10 at 8:50pm via tobiratherapeutics.com

Investments

Videos

Sources

1. PeHub (pehub.com) [edit]
2. Carticept Medical Closes $10M Financing (finsmes.com) [edit]
3. Aria Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing (ariadx.com) [edit]
4. IntegenX Secures $40M in Series C Funding (finsmes.com) [edit]
5. Sera Secures $19.3 million Financing; Appoints Greg C. Critchfield, MD as Chief Executive Officer (seraprognostics.com) [edit]
6. CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million (prnewswire.com) [edit]
7. Benvenue Medical raises $35.5M (bizjournals.com) [edit]
8. CoDa Therapeutics Inks $19.2M Series B (pehub.com) [edit]
9. BioNanomatrix Secures $23.3 Million in Series B Financing (bionanomatrix.com) [edit]
10. Astute Medical Completes $13 Million Financing With Existing Stockholders (money.msn.com) [edit]
11. IntegenX raises $15.6M, buys GenVault (bizjournals.com) [edit]
12. aTyr Pharma Secures $23M Financing From Top Tier Venture Investor (atyrpharma.com) [edit]
13. Cell Biosciences Nabs $20M (xconomy.com) [edit]
14. Tobira Therapeutics Inc. Raises $31 Million in Series B Financing (tobiratherapeutics.com) [edit]
15. Eddingpharm (Cayman) Closes $24M Series B Funding (finsmes.com) [edit]
16. CELATOR® PHARMACEUTICALS RAISES $20 MILLION IN SERIES D FINANCING (celatorpharma.com) [edit]
17. Otonomy Closes $38.5 Million Series B Financing (otonomy.com) [edit]
18. Achillion Announces Private Placement of $50 Million (ir.achillion.com) [edit]
19. Nuon Therapeutics raises $10M in new funding (bizjournals.com) [edit]
20. ReVision Optics, Inc.: Series D $35M (onbiovc.com) [edit]
21. Zogenix Secures $35 Million Debt Facility And Raises $15 Million Investment Capital (zogenix.com) [edit]
22. Arginetix and Immune Control Merge to Form Corridor Pharmaceuticals (finance.yahoo.com) [edit]
23. Veracyte, Inc.: Series B $28M (onbiovc.com) [edit]
24. Sequent Medical, Inc.: Series B $15.6M (onbiovc.com) [edit]
25. Astute Medical, Inc.: Series B $26.5M (onbiovc.com) [edit]
26. Tragara Pharmaceuticals, Inc.: Series B $5M (onbiovc.com) [edit]
27. Achaogen Completes $56 Million Series C Financing (pr-inside.com) [edit]
28. Nuon captures $6.05M to develop treatments for autoimmune disease (deals.venturebeat.com) [edit]
29. Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]
30. AltAssets (altassets.com) [edit]
31. Altair Therapeutics, Inc.: Series B $17M (onbiovc.com) [edit]
32. VentiRx Pharma Extends Series A To $51.6M (fis.dowjones.com) [edit]
33. Regado Biosciences Stays Patient, Looks To Europe With New $40M (fis.dowjones.com) [edit]
34. Afferent Pharmaceuticals Closes $23M Series A Financing Round (finsmes.com) [edit]
35. Apnex Medical, Inc. Raises Additional $14 Million (apnexmedical.com) [edit]
36. Microchip Biotechnologies Raises $18.1M in Series B Financing (sanfrancisco.bizjournals.com) [edit]
37. SEC D (sec.gov) [edit]
38. Alimera Sciences, Inc.: Series C $5M (onbiovc.com) [edit]
39. Oraya garners $42M in third venture round (fiercebiotech.com) [edit]
40. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
41. Marinus Pharmaceuticals, Inc.: Series B $20M (onbiovc.com) [edit]
42. Cell Biosciences Raises $10 Million (pehub.com) [edit]
43. BiPar Sciences Raises $20 Million to Advance Clinical Programs (biparsciences.com) [edit]
44. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
45. Equity Help Desk (equityhelpdesk.com) [edit]
46. Capital Funding Report [edit]
47. Esperion Therapeutics Completes $22.75M Series A Financing (esperion.com) [edit]
48. Nuon Therapeutics, Inc. Completes $27 Million Series B Financing (nuontherapeutics.com) [edit]
49. BioVascular Inc. Closes $10.87 Million Series C Financing (salesandmarketingnetwork.com) [edit]
50. Sonexa Therapeutics, Inc. Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments (biospace.com) [edit]
51. Zogenix Raises $18 Million in Preferred Stock Financing (zogenix.com) [edit]
52. Corthera Closes $23 Million Financing Round (basmedical.com) [edit]
53. Asmacure closes US$9 million Series A financing (fasken.com) [edit]
54. DiObex, a metabolic disease treatment co., raises $24M (deals.venturebeat.com) [edit]
55. GenVault Corporation Raises $18 Million of Financing (genvault.com) [edit]
56. BiPar Sciences Raises $35 Million to Advance Pipeline of Novel PARP Inhibitor Cancer Drug Candidates (biparsciences.com) [edit]
57. Achaogen Closes Series B Financing (achaogen.com) [edit]
58. CoDa Therapeutics Announces Series A Financing (codatherapeutics.com) [edit]
59. Zogenix, Inc. Raises $60 Million In Series A Venture Financing; Names Board of Directors (zogenix.com) [edit]
60. Bio-Medicine (bio-medicine.org) [edit]
61. Celladon Secures $30 Million in Series B Financing. (thefreelibrary.com) [edit]
62. Alimera Sciences Secures $31.8 Million in Series B Financing (gabio.org) [edit]
63. Cap Funding Report [edit]
64. Five Prime Therapeutics, Inc. Raises $45MM in Private Financing (fiveprime.com) [edit]